Distinct gut virome profile of pregnant women with type 1 diabetes in the ENDIA study

This abstract has open access
Abstract Summary

BACKGROUND: The importance of gut bacteria in human physiology, immune regulation and disease pathogenesis is well established. In contrast, the composition and dynamics of the gut virome (the viral component of the microbiome) remain largely unknown in adults including pregnant women. Viruses are implicated as potential triggers and/or accelerants of many diseases including type 1 diabetes (T1D), and to date, no study has comprehensively examined the gut virome during pregnancy, and how it may be altered by T1D.

METHODS: Comprehensive virome capture sequencing (VirCapSeq-VERT) was used to characterise the gut virome of 61 pregnant women (35 with T1D and 26 without) longitudinally followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) - an Australian prospective cohort study of children at risk of T1D (> 1 first-degree relative with T1D) followed from pregnancy. Women were recruited between 2012-2016. Fecal samples (n=124) were collected during the first (n=18), second (n=47) and/or third trimester of pregnancy (n=59), defined as gestational age (weeks) of 1-14, 15-26 and 27-42, respectively. Maternal T1D and virus positivity examined using generalised estimating equations. Differential abundance analysed using edgeR in R (version 3.3.0).

RESULTS: 63% of samples (78/124) tested positive for >1 virus. Picobirnavirus, Parechovirus and Enteroviruses were among the most frequent genera of vertebrate-infecting viruses and there was a trend to higher virus positivity in mothers with T1D. After adjusting for maternal age, two viruses remained more prevalent in women with T1D: Picobirnavirus (OR 4.2, 95% CI 1.0?17.1; p=0.046) and Tobamovirus (OR 3.2, 1.1-9.3; p=0.037). Furthermore, 77 viruses were differentially abundant between the two maternal groups (?2-fold difference; p<0.02), including 8 enterovirus B genotypes present at a higher abundance in women with T1D. These findings provide novel insight into the composition of the gut virome during pregnancy and demonstrate a distinct virus profile in women with T1D.

Submission ID :
IDS4241
Submission Type
Abstract Topics
School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia
Hunter Diabetes Centre, Newcastle, Australia
School of Biotechnology and Biomolecular Science, University of New South Wales, Sydney, Australia
The Walter & Eliza Hall Institute of Medical Research, Melbourne, Australia
Robinson Research Institute, University of Adelaide , Australia
Department of Computing and Information Systems, University of Melbourne, Melbourne, Australia
Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Robinson Research Institute, University of Adelaide , Australia
School of Medicine, Deakin University, Geelong, Australia
Royal Melbourne Hospital and Walter and Eliza Hall Institute
School of Biotechnology and Biomolecular Science, University of New South Wales, Sydney, Australia
Serology and Virology Division, SEALS Microbiology, Prince of Wales Hospital, Sydney, Australia
Childrens Hospital at Westmead, NSW, Australia
Harry Perkins Institute of Medical Research, Perth
Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, USA
School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia
Columbia University
Robinson Research Institute, University of Adelaide , Australia
Robinson Research Institute
Royal Melbourne Hospital, Vic, Australia
Children’s Health Queensland Hospital and Health Service
Telethon Kids Institute, The University of Western Australia, Perth, Australia
University of Adelaide
Walter and Eliza Hall Institute
Children’s Health Queensland Hospital and Health Service, Queensland, Australia
Telethon Kids Institute, The University of Western Australia, Perth, Australia
School of Women’s and Children’s Health, University of New South Wales, Sydney, Australia

Abstracts With Same Type

Submission ID
Submission Title
Submission Topic
Submission Type
Primary Author
5 visits

KEY DATES

Event dates:
Thursday 25 October - Monday 29 October 2018

Abstract submission deadline:
Monday 14 May 2018

Abstract notification:
July 2018

Early registration deadline:
Monday 3 September 2018

Registration deadline:
Monday 15 October 2018

Contact
British Society for Immunology
+44 (0)20 3019 5901
congress@immunology.org